Cited by 11Neurogenesis and neuroplasticity mechanismsNeuroinflammation and Neurodegeneration MechanismsGenetic Neurodegenerative Diseases

Striatal oligodendrogliogenesis and neuroblast recruitment are increased in the R6/2 mouse model of Huntington's disease

Open access
McCollum, Mark H., Leon, Rebecca T., Rush, Daniel B., Guthrie, Kathleen M., Wei, Jianning·2013·Brain Research

Abstract

The subventricular zone (SVZ) is one of the two major neurogenic regions in the adult mammalian brain. Its close proximity to the striatum suggests that a cell-based therapeutic strategy for the treatment of Huntington's disease (HD) is possible. To achieve this, it is important to understand how adult cell production, migration and differentiation may be altered in the HD brain. In this study, we quantified the number of adult-born striatal cells and characterized their fate in the R6/2 transgenic mouse model of HD. We found that the number of new striatal cells was approximately two-fold greater in R6/2 vs. wild type mice, while SVZ cell proliferation was not affected. Using cell-type specific markers, we demonstrated that the majority of new striatal cells were mature oligodendrocytes or oligodendroglial precursors that were intrinsic to the striatum. We also detected a significant increase in the number of migrating neuroblasts that appeared to be recruited from the SVZ to the striatum. However, these neuroblasts did not mature into neurons and most were lost between 1 and 2 weeks of cell age. Crossing the R6/2 mice with mice the over-expressing brain-derived neurotrophic factor in the striatum increased the numbers of neuroblasts that survived to 2 weeks, but did not promote their differentiation. Together, our data indicate that the potential treatment of HD based on manipulating endogenous progenitor cells should take into consideration the apparent enhancement in striatal oligodendrogliogenesis and the limited ability of recruited SVZ neuroblasts to survive long-term and differentiate in the diseased striatum.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.brainres.2013.04.030

Cites

55 of 55 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
McCollum, M. H., Leon, R. T., Rush, D. B., Guthrie, K. M., & Wei, J.
Affiliations
Florida Atlantic University (US)
Corresponding author
Wei, Jianning
Venue
Brain Research
Publisher
Elsevier BV
Published
2013-06
Volume
1518
Pages
91-103
ISSN
0006-8993 (ISSN-L)
OpenAlex
W2056273928
Cited by
11
References
55
Citations by year
2026: 1 · 2025: 2 · 2023: 1 · 2021: 1 · 2020: 1 · 2019: 2 · 2016: 2 · 2015: 1
FWCI
0.37
Type
journal article
Language
en
Open access
Locations
  • Brain Research (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Institute of Neurological Disorders and Stroke (R15NS066339)
Topics
  • Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
Keywords
Huntington's disease, R6/2 transgenic mice, striatum, adult neurogenesis, subventricular zone, oligodendrocytes, neuroblast migration, brain-derived neurotrophic factor, cell therapy
MeSH terms
Oligodendrocyte Transcription Factor 2, Animals, Bromodeoxyuridine, Cell Count, Cell Differentiation, Cerebral Ventricles, Corpus Striatum, Disease Models, Animal, Gene Expression Regulation, Huntington Disease, Mice, Mutant Strains, Nerve Tissue Proteins, Oligodendroglia, Time Factors, Neoplastic Stem Cells, Brain-Derived Neurotrophic Factor, Cell Proliferation, Mice, Basic Helix-Loop-Helix Proteins, Neural Stem Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review